Navigation Links
Developing a Safer and More Effective Way to Deliver Rabies Antibodies
Date:2/5/2009

INCHEON, South Korea, Feb. 5 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) and Celltrion, Inc., a South Korean biopharmaceutical company, have signed a Letter of Intent to permit joint research on the development of novel antibodies to protect people exposed to the rabies virus.

Medical attention for a person exposed to rabies is a two-step procedure. First, rabies immune globulin (RIG) is given to provide immediate antibodies neutralizing the rabies virus. Thereafter, the patient receives five doses of vaccine to build active immunity against the rabies virus.

Active immunity is detectable after the first week of vaccination so RIG is essential at the first stage of medical attention before a person develops their own antibodies from vaccine.

There are currently two types of RIG: human and equine. Human RIG can sometimes be in short supply due to manufacturing restrictions. It is expensive, and there are regulatory concerns because it comes from human blood. Because equine RIG is derived from horses, there are concerns that it may not provide the proper antibody response, and there are international animal care and use issues because of the involvement of horses in its production. In developing countries, where the majority of human rabies cases occur, both types of RIG are frequently unavailable.

The CDC/Celltrion collaboration addresses these problems by using cell culture to manufacture RIG of a new generation, which is expected to be safer, more effective and affordable.

"The CDC is excited to begin a novel research collaboration with Celltrion on the development of additional products that can provide immunity to rabies. We believe this effort holds great public health promise toward the prevention of this deadly disease, especially in developing countries," said Charles E. Rupprecht, V.M.D., chief of the CDC's Rabies Program.

Rabies is a viral disease of mammals which is transmitted through the bite of infected animals. The virus infects the central nervous system, causing inflammation of the brain and ultimately death, if medical assistance is not sought promptly after the exposure to prevent the disease. Rabies is particularly prevalent in Eastern Europe, Asia, South America, and Africa. An estimated 40,000 to 70,000 people die of the disease each year, mainly in Asia and Africa.

About Celltrion: Celltrion, established in 2002, is a contract manufacturing organization with its headquarters in Incheon, South Korea. Celltrion, an emerging leader in the biopharmaceutical industry, is dedicated to providing high quality services to accelerate product development, while offering scalable manufacturing capabilities for our clients and business partners. Celltrion is also investing in research and development of its own products in order to develop into a fully integrated biotechnology company. For more information, please visit Celltrion's website at http://www.celltrion.com.

     For additional information, please contact:
     Seung-Suh (Stanley) Hong, Ph.D.
     Senior Vice President, Business Development
     Celltrion, Inc. (USA)
     E-mail:  seungsuh.hong@celltrion.com
     Tel:  +1-650-766-2307

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of Celltrion as of the date of this release. These forward- looking statements are no guarantees for future performance, and the forward- looking events discussed in this press release may not occur. Celltrion disclaims any intent or obligation to update any of these forward-looking statements.


'/>"/>
SOURCE Celltrion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
5. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
6. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
7. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. Iowa State researchers developing system to efficiently convert biomass to ethanol
10. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
11. Developing Sales Leaders: Benchmarks Reveal Tactics that Will Propel Your Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation ... infertility as a disease, bringing new hope for prospective parents who are challenged ... meeting to back the World Health Organization’s designation in hopes of changing the ...
(Date:6/22/2017)... ... June 22, 2017 , ... Tunnell Consulting’s ... and life sciences industries, continue to be in demand for their insights and ... be speaking on “The State of Information Governance in the Biopharmaceutical Industry” at ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... the release of Limfinity® version 6.5, a content-packed update to the Limfinity® framework. ... gain a larger and more diverse base of customers among labs and other ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... board of directors has formed a Higher Education Entrepreneurship Advisory Committee to implement ... institution presidents and other high-ranking representatives from 35 higher education institutions across the ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
(Date:3/22/2017)... March 21, 2017 Vigilant Solutions , ... law enforcement agencies, announced today the appointment of retired ... of public safety business development. Mr. Sheridan ... experience, including a focus on the aviation transportation sector, ... recent position, Mr. Sheridan served as the Aviation Liaison ...
Breaking Biology News(10 mins):